NEWS

Phenex Pharmaceuticals AG’s presentation at EASL the International Liver CongressTM 2019 in Vienna, Austria.

News Release 2019.04.15

SMC announced that Phenex Pharmaceuticals AG presented results of a study using STAM model at oral presentation at EASL the International Liver CongressTM 2019 in Vienna, Austria, April 10-19, 2019.

Title: LXR inverse agonists reduce steatosis and fibrosis in the STAM mouse model but also improve insulin sensitivity in a high fat diet mouse clamp study